LIMAF(LIMAF)
LIMAF
No analyst ratings available
No analyst price targets available for LIMAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $11.78B | $12.19B |
| Low | $11.65B | $11.99B |
| High | $11.92B | $12.46B |
| EBITDA Avg | $1.60B | $1.66B |
| Low | $1.58B | $1.63B |
| High | $1.62B | $1.69B |
| EBIT Avg | $913M | $944M |
| Low | $902M | $929M |
| High | $923M | $965M |
| Net Income Avg | $718M | $799M |
| Low | $705M | $785M |
| High | $734M | $817M |
| EPS Avg | $11.98 | $13.34 |
| Low | $11.77 | $13.10 |
| High | $12.25 | $13.63 |
| Analysts (Rev / EPS) | 5 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2.99B | $2.79B | $3.16B | $3.35B | $3.11B | $2.78B |
| Low | $2.96B | $2.76B | $3.12B | $3.31B | $3.08B | $2.75B |
| High | $3.05B | $2.85B | $3.22B | $3.42B | $3.18B | $2.84B |
| EBITDA Avg | $406M | $380M | $430M | $456M | $424M | $379M |
| Low | $402M | $375M | $425M | $451M | $419M | $374M |
| High | $415M | $388M | $439M | $465M | $432M | $387M |
| EBIT Avg | $231M | $216M | $245M | $259M | $241M | $216M |
| Low | $229M | $214M | $242M | $257M | $238M | $213M |
| High | $236M | $221M | $250M | $265M | $246M | $220M |
| Net Income Avg | $175M | $154M | $213M | $217M | $194M | $176M |
| Low | $173M | $152M | $210M | $214M | $191M | $173M |
| High | $180M | $158M | $219M | $223M | $199M | $181M |
| EPS Avg | $2.94 | $2.59 | $3.58 | $3.66 | $3.26 | $2.96 |
| Low | $2.90 | $2.55 | $3.53 | $3.61 | $3.22 | $2.92 |
| High | $3.02 | $2.66 | $3.68 | $3.76 | $3.35 | $3.04 |
| Analysts (Rev / EPS) | 3 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |